Department of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden.
Mol Aspects Med. 2013 Apr-Jun;34(2-3):571-85. doi: 10.1016/j.mam.2012.07.012.
About 25% of all solute carriers (SLCs) are likely to transport amino acids as their primary substrate. One of the major phylogenetic clusters of amino acid transporters from the SLC family is the β-family, which is part of the PFAM APC clan. The β-family includes three SLC families, SLC32, SLC36 and SLC38 with one, four and eleven members in humans, respectively. The most well characterized genes within these families are the vesicular inhibitory amino acid transporter (VIAAT, SLC32A1), PAT1 (SLC36A1), PAT2 (SLC36A2), PAT4 (SLC36A4), SNAT1 (SLC38A1), SNAT2 (SLC38A2), SNAT3 (SLC38A3), and SNAT4 (SLC38A4). Here we review the structural characteristics and functional role of these transporters. We also mined the complete protein sequence datasets for nine different genomes to clarify the evolutionary history of the β-family of transporters. We show that all three main branches of the this family are found as far back as green algae suggesting that genes from these families existed in the early eukaryote before the split of animals and plants and that they are present in most animal species. We also address the potential of further drug development within this field highlighting the important role of these transporters in neurotransmission and transport of amino acids as nutrients.
大约 25%的溶质载体(SLCs)可能将氨基酸作为其主要底物进行运输。SLC 家族中的氨基酸转运蛋白主要进化簇之一是β家族,它是 PFAM APC 族的一部分。β 家族包括 SLC32、SLC36 和 SLC38 三个 SLC 家族,分别在人类中有一个、四个和十一个成员。这些家族中最具特征的基因是囊泡抑制性氨基酸转运蛋白(VIAAT,SLC32A1)、PAT1(SLC36A1)、PAT2(SLC36A2)、PAT4(SLC36A4)、SNAT1(SLC38A1)、SNAT2(SLC38A2)、SNAT3(SLC38A3)和 SNAT4(SLC38A4)。本文综述了这些转运蛋白的结构特征和功能作用。我们还挖掘了九个不同基因组的完整蛋白质序列数据集,以阐明β-家族转运蛋白的进化历史。我们表明,该家族的三个主要分支早在绿藻中就已存在,这表明这些家族的基因存在于动植物分化之前的早期真核生物中,并且它们存在于大多数动物物种中。我们还探讨了该领域进一步药物开发的潜力,强调了这些转运蛋白在神经递质传递和氨基酸作为营养物质的运输中的重要作用。